Ocular implant containing a tyrosine kinase inhibitor

MYPI2025001820A0Undetermined Publication Date: 2021-09-25OCULAR THERAPEUTIX INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025001820
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-02-11
Filing Date
2021-03-24
Publication Date
2021-09-25
Patent Text Reader

Abstract

The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time. (Figure 1)
Need to check novelty before this filing date? Find Prior Art